yohimbine has been researched along with Brain Ischemia in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (42.11) | 18.7374 |
| 1990's | 6 (31.58) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 1 (5.26) | 24.3611 |
| 2020's | 2 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, Y; He, Z; Li, ZC; Yang, DD; Zhang, J; Zhao, B | 1 |
| Matsuura, W; Nakamoto, K; Tokuyama, S | 1 |
| Nakano, T; Okamoto, H | 1 |
| Milot, MR; Plamondon, H | 1 |
| Delorme, P | 2 |
| Actis, H; Dellazuana, O; Duhault, J; Roman, F | 1 |
| Kvaltínová, Z; Lukovic, L; Stolc, S | 1 |
| Chan, P; Guez, D; Hu, P; Li, Y; Sarbach, SD; Zheng, Z | 1 |
| Chan, P | 1 |
| Allain, H; Bentué-Ferrer, D | 1 |
| Cattelin, F; Depresseux, JC; Franck, G; Van Cauwenberge, H | 1 |
| Allain, H; Bentué-Ferrer, D; Decombe, R; Reymann, JM; Schatz, C | 1 |
| Depresseux, JC; Franck, G; Van Cauwenberge, H | 1 |
| Guez, D | 1 |
| Labrid, C | 1 |
| Mémin, Y | 1 |
3 review(s) available for yohimbine and Brain Ischemia
| Article | Year |
|---|---|
Pathophysiology of postischemic hypoxia and cerebral protection: implications of the almitrine and raubasine combination.
Topics: Almitrine; Animals; Brain Ischemia; Drug Combinations; Hypoxia, Brain; Ischemic Attack, Transient; Neuroprotective Agents; Piperazines; Secologanin Tryptamine Alkaloids; Treatment Outcome; Yohimbine | 1995 |
Progress in understanding the pathophysiology of cerebral ischemia: the almitrine-raubasine approach.
Topics: Almitrine; Animals; Brain Ischemia; Disease Models, Animal; Drug Combinations; Humans; Secologanin Tryptamine Alkaloids; Yohimbine | 1990 |
[Experimental models in cerebral ischemia: application to the study of duxil].
Topics: Almitrine; Animals; Brain Ischemia; Cats; Cerebral Arteries; Disease Models, Animal; Dogs; Drug Combinations; Gerbillinae; Humans; Piperazines; Rabbits; Rats; Yohimbine | 1988 |
16 other study(ies) available for yohimbine and Brain Ischemia
| Article | Year |
|---|---|
Clonidine ameliorates cerebral ischemia-reperfusion injury by up-regulating the GluN3 subunits of NMDA receptor.
Topics: Animals; Brain Ischemia; Clonidine; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury; Yohimbine | 2022 |
Involvement of descending pain control system regulated by orexin receptor signaling in the induction of central post-stroke pain in mice.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Benzoxazoles; Brain; Brain Ischemia; Hyperalgesia; Isoquinolines; Male; Mice; Mitochondrial Proteins; Naphthyridines; Neuralgia; Orexin Receptor Antagonists; Orexin Receptors; Orexins; Piperazines; Pyridines; Serotonin Antagonists; Signal Transduction; Urea; Yohimbine | 2020 |
Dexmedetomidine-induced cerebral hypoperfusion exacerbates ischemic brain injury in rats.
Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; Brain Ischemia; Cerebrovascular Circulation; Dexmedetomidine; Hypnotics and Sedatives; Infarction, Middle Cerebral Artery; Male; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Vascular Resistance; Yohimbine | 2009 |
Changes in HPA reactivity and noradrenergic functions regulate spatial memory impairments at delayed time intervals following cerebral ischemia.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Analysis of Variance; Animals; Brain; Brain Ischemia; Clonidine; Corticosterone; Hypothalamo-Hypophyseal System; Male; Maze Learning; Memory; Neurons; Norepinephrine; Pituitary-Adrenal System; Rats; Rats, Wistar; Time Factors; Yohimbine | 2011 |
[Ultrastructural study of acute ischemia at the cerebral level. Effects of 5023 SE].
Topics: Acute Disease; Almitrine; Animals; Brain Ischemia; Disease Models, Animal; Drug Combinations; Microscopy, Electron; Piperazines; Rabbits; Telencephalon; Time Factors; Yohimbine | 1983 |
[Effects of 5023 SE on experimental cerebral ischemia in gerbils].
Topics: Almitrine; Animals; Brain Ischemia; Disease Models, Animal; Drug Combinations; Gerbillinae; Piperazines; Time Factors; Yohimbine | 1983 |
[Ultrastructural study of acute ischemia at the peripheral level. Effects of 5023 SE].
Topics: Acute Disease; Almitrine; Animals; Brain Ischemia; Carotid Arteries; Disease Models, Animal; Drug Combinations; Endothelium; Microscopy, Electron; Piperazines; Rabbits; Yohimbine | 1983 |
Effect of incomplete ischemia and reperfusion of the rat brain on the density and affinity of alpha-adrenergic binding sites in the cerebral cortex. Prevention of changes by stobadine and vitamin E.
Topics: Animals; Antioxidants; Brain Ischemia; Carbolines; Cerebral Cortex; Dihydroergotoxine; Free Radicals; Kinetics; Male; Membranes; Rats; Rats, Wistar; Reactive Oxygen Species; Receptors, Adrenergic, alpha; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Reperfusion; Vitamin E; Yohimbine | 1993 |
Neurologic and histologic evaluation of almitrine+raubasine (Duxil) in middle cerebral artery occlusion in cats.
Topics: Almitrine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Brain; Brain Chemistry; Brain Ischemia; Cats; Cerebral Arteries; Female; Glycogen; Male; Mitochondria; Secologanin Tryptamine Alkaloids; Yohimbine | 1993 |
Cerebral ischemia: from pharmacology to modern techniques and clinical implications. Value of almitrine-raubasin (Duxil Duxaril). International symposium, Hangzhou, People's Republic of China, May 14, 1994.
Topics: Almitrine; Brain Ischemia; Drug Combinations; Humans; Neuroprotective Agents; Piperazines; Secologanin Tryptamine Alkaloids; Yohimbine | 1995 |
[Effect of almitrine/raubasine on cerebral metabolism in the elderly].
Topics: Aged; Almitrine; Alzheimer Disease; Animals; Brain; Brain Ischemia; Energy Metabolism; Humans; Neurons; Nootropic Agents; Oxygen Consumption; Secologanin Tryptamine Alkaloids; Yohimbine | 2002 |
Metabolic and circulatory evaluation of cerebral ischemic accident in humans by positron emission tomography: a pilot study with almitrine-raubasine.
Topics: Aged; Almitrine; Brain Ischemia; Cerebrovascular Circulation; Drug Combinations; Female; Humans; Male; Middle Aged; Oxygen Consumption; Pilot Projects; Secologanin Tryptamine Alkaloids; Tomography, Emission-Computed; Yohimbine | 1990 |
[Metabolic and blood circulation evaluation of acute ischemic cerebral accident in humans using positron emission tomography].
Topics: Acute Disease; Aged; Almitrine; Anti-Inflammatory Agents, Non-Steroidal; Brain Ischemia; Central Nervous System Stimulants; Cerebrovascular Circulation; Drug Combinations; Female; Humans; Male; Middle Aged; Oxygen Consumption; Piperazines; Secologanin Tryptamine Alkaloids; Tomography, Emission-Computed; Yohimbine | 1987 |
[Evaluation of acute and chronic cerebral ischemia in man by positron and single photon emission tomography: application to the study of duxil].
Topics: Acute Disease; Aged; Almitrine; Brain Ischemia; Cerebrovascular Circulation; Chronic Disease; Drug Combinations; Female; Humans; Male; Middle Aged; Oxygen Consumption; Piperazines; Tomography, Emission-Computed; Yohimbine | 1988 |
[First Forum on Updates on Cerebral Ischemia Pathology. Seville, 1-4 October 1987. Proceedings].
Topics: Almitrine; Brain Ischemia; Drug Combinations; Humans; Piperazines; Yohimbine | 1988 |
[Evaluation of the therapeutic effect of duxil in chronic cerebral insufficiency. Analysis of 4636 patients at cerebrovascular risk].
Topics: Aged; Almitrine; Attention; Brain Ischemia; Chronic Disease; Drug Combinations; Humans; Hypoxia, Brain; Memory; Middle Aged; Piperazines; Risk Factors; Yohimbine | 1988 |